Outcome and prognostic factors in patients with mantle-cell lymphoma relapsing after autologous stem-cell transplantation: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT)

S. Dietrich*, A. Boumendil, H. Finel, I. Avivi, L. Volin, J. Cornelissen, R. J. Jarosinska, C. Schmid, J. Finke, W. B. C. Stevens, H. C. Schouten, M. Kaufmann, C. Sebban, M. Trneny, G. Kobbe, L. M. Fornecker, J. Schetelig, E. Kanfer, T. Heinicke, M. PfreundschuhJ. L. Diez-Martin, D. Bordessoule, S. Robinson, P. Dreger

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1053-1058
JournalAnnals of Oncology
Volume25
Issue number5
DOIs
Publication statusPublished - May 2014

Keywords

  • mantle cell lymphoma relapse
  • autologous stem-cell transplantation
  • allogeneic stem-cell transplantation

Cite this